Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Buhmann

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Frontiers in Neurology|December 19, 2022
Driving ability and predictors for driving performance in Multiple Sclerosis: A systematic reviewSusan Seddiq Zai, Christoph Heesen, Carsten Buhmann, et al.
Fortschritte Der Neurologie-Psychiatrie|April 18, 2020
[The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care]Odette Fründt, Ermir Veliqi, Beate Schönwald, et al.
European Neurology|March 21, 2003
Effects of mitoxantrone on multiple sclerosis patients' lymphocyte subpopulations and production of immunoglobulin, TNF-alpha and IL-10Joystone Gbadamosi, Carsten Buhmann, Wiebke Tessmer, et al.
Acta Ophthalmologica|August 13, 2015
Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomographyDiana Bittersohl, Birthe Stemplewitz, Matthias Keserü, et al.
Pain|July 18, 2017
Altered neural responses to heat pain in drug-naive patients with Parkinson diseaseKatarina Forkmann, Wiebke Grashorn, Katharina Schmidt, et al.
Neurological Research and Practice|December 16, 2020
Conditioned pain modulation in drug-naïve patients with de novo Parkinson's diseaseWiebke Grashorn, Odette Fründt, Carsten Buhmann, et al.
Journal of Neurology|June 8, 2026
Effect of subcutaneous foslevodopa/foscarbidopa therapy on non-motor symptoms in advanced PD patientsAlina Jander, Sarah Bergner, Beate Schönwald, et al.
European Neurology|May 1, 2015
Visual Attention and Saccadic Oculomotor Control in Parkinson's DiseaseCarsten Buhmann, Stefanie Kraft, Kim Hinkelmann, et al.
Frontiers in Aging Neuroscience|September 26, 2025
Subcutaneous foslevodopa/foscarbidopa initiation in a Parkinson's day-clinic - a suitable setting to ensure treatment efficacy, tolerability and psychosocial adaptionAlina Jander, Sarah Bergner, Beate Schönwald, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2022
Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)Carsten Buhmann, Susanne Lezius, Monika Pötter-Nerger, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Frontiers in Neurology|December 19, 2022
Driving ability and predictors for driving performance in Multiple Sclerosis: A systematic reviewSusan Seddiq Zai, Christoph Heesen, Carsten Buhmann, et al.
Fortschritte Der Neurologie-Psychiatrie|April 18, 2020
[The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care]Odette Fründt, Ermir Veliqi, Beate Schönwald, et al.
European Neurology|March 21, 2003
Effects of mitoxantrone on multiple sclerosis patients' lymphocyte subpopulations and production of immunoglobulin, TNF-alpha and IL-10Joystone Gbadamosi, Carsten Buhmann, Wiebke Tessmer, et al.
Acta Ophthalmologica|August 13, 2015
Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomographyDiana Bittersohl, Birthe Stemplewitz, Matthias Keserü, et al.
Pain|July 18, 2017
Altered neural responses to heat pain in drug-naive patients with Parkinson diseaseKatarina Forkmann, Wiebke Grashorn, Katharina Schmidt, et al.
Neurological Research and Practice|December 16, 2020
Conditioned pain modulation in drug-naïve patients with de novo Parkinson's diseaseWiebke Grashorn, Odette Fründt, Carsten Buhmann, et al.
Journal of Neurology|June 8, 2026
Effect of subcutaneous foslevodopa/foscarbidopa therapy on non-motor symptoms in advanced PD patientsAlina Jander, Sarah Bergner, Beate Schönwald, et al.
European Neurology|May 1, 2015
Visual Attention and Saccadic Oculomotor Control in Parkinson's DiseaseCarsten Buhmann, Stefanie Kraft, Kim Hinkelmann, et al.
Frontiers in Aging Neuroscience|September 26, 2025
Subcutaneous foslevodopa/foscarbidopa initiation in a Parkinson's day-clinic - a suitable setting to ensure treatment efficacy, tolerability and psychosocial adaptionAlina Jander, Sarah Bergner, Beate Schönwald, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2022
Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)Carsten Buhmann, Susanne Lezius, Monika Pötter-Nerger, et al.
Pageof 12